Panel Discussion
Whatever one’s views about goals and targets, it is clear enough that there has been a strengthened focus in Australia in recent years on bringing critical interventions and technologies, such as treatment, rapid testing and PrEP, to scale. This welcome focus has seen newfound energy and great effort directed to improving access to HIV testing and treatment. Much of this effort has been driven by the imperative of the 2020 goal and under the Ending HIV banner.
What then, of 2020? While great effort has been expended on the journey to 2020, there has been less discussion of what we’ll find when we arrive. Will HIV be over? Will we truly be ‘switching off the lights’ as has been suggested? Hardly. To presume so is to misunderstand the rhetorical device of Ending HIV and the mobilising intent of ambitious goals. But if HIV will still be here, then in what ways will it be here? At what intensity? Affecting whom? What of our organisations and workforce? And how best can we plan now for this future?
Join us for what will be an engaging panel discussion on HIV in 2020.
Facilitator: Bridget Haire
Jared Baeten, Vice Chair and Professor, University of Washington, USA
Levinia Crooks, CEO, ASHM
Andrew Grulich, Kirby Institute, UNSW Australia
Richard Keane, President, Living Positive Victoria
Darryl O'Donnell, Australian Federation of AIDS Organisations, Australia
Matthew Weait, Dean, Faculty of Humanities and Social Sciences, University of Portsmouth
James Ward, Head Infectious Diseases Aboriginal Health, South Australian Health and Medical Research Institute, SA, Australia